Abstract
The mechanisms that specify and stabilize cell subtypes remain poorly understood. Here, we identify two major subtypes of pancreatic β cells based on histone mark heterogeneity (βHI and βLO). βHI cells exhibit ∼4-fold higher levels of H3K27me3, distinct chromatin organization and compaction, and a specific transcriptional pattern. βHI and βLO cells also differ in size, morphology, cytosolic and nuclear ultrastructure, epigenomes, cell surface marker expression, and function, and can be FACS separated into CD24+ and CD24− fractions. Functionally, βHI cells have increased mitochondrial mass, activity, and insulin secretion in vivo and ex vivo. Partial loss of function indicates that H3K27me3 dosage regulates βHI/βLO ratio in vivo, suggesting that control of β cell subtype identity and ratio is at least partially uncoupled. Both subtypes are conserved in humans, with βHI cells enriched in humans with type 2 diabetes. Thus, epigenetic dosage is a novel regulator of cell subtype specification and identifies two functionally distinct β cell subtypes.
| Original language | English |
|---|---|
| Pages (from-to) | 821-836.e7 |
| Journal | Cell Metabolism |
| Volume | 35 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2 May 2023 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2023 The Author(s)
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- H3K27me3
- beta cells
- bivalent genes
- cell heterogeneity
- chromatin organization
- epigenetics
- insulin
- pancreatic islet
- single cell
Fingerprint
Dive into the research topics of 'Epigenetic dosage identifies two major and functionally distinct β cell subtypes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver